Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canna-V-Cell Sciences (OP: CNVCF )

0.1480 +0.0018 (+1.23%)
Streaming Delayed Price Updated: 11:35 AM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Canna-V-Cell Sciences

< Previous 1 2 Next >
BioHarvest Sciences Inc. Announces $11.78M Raised in First Tranche of $13.5M Private Placement
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada
Significant milestone marking the beginning of VINIA® geographical expansion beyond Israel and the US Further validation from global health authorities... 
Via Newsfile
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
Significant milestone demonstrating sales momentum of VINIA®Further validation of the Botanical Synthesis Technology PlatformStrong justification of the Direct-to-Consumer sales strategyVancouver,... 
Via Newsfile
BioHarvest Sciences Reports Q2 2023 Results Demonstrating Continued Growth Momentum
Q2 VINIA® revenues of USD 2.75M represent growth of 228% compared to Q2 2022 and 27% compared to Q1 2023... 
Via Newsfile
BioHarvest Sciences to Host Virtual Shareholder Presentation September 6, 2023
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 24, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the... 
Via Newsfile
BioHarvest Sciences Inc. Announces Closing of Private Placement of Convertible Notes
This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.Vancouver,... 
Via Newsfile
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of... 
Via Newsfile
BioHarvest Sciences Chief Medical Officer to Speak at Collision Conference in Toronto
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:... 
Via Newsfile
BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA
Celebrating two years since launch of VINIA® into the USNew categories have potential for significant impact on financial results starting... 
Via Newsfile
BioHarvest Sciences Adds Renowned Scientist to Scientific Advisory Board
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that... 
Via Newsfile
BioHarvest Reports Q1 2023 Results Demonstrating Strong Year Over Year Growth
VINIA® revenues grew 209% compared to Q1 2022 to reach USD 2.2 MReiterating guidance for year-on-year revenue growth of 3... 
Via Newsfile
Topics Economy
Exposures Supply Chain
BioHarvest Adds over 25,000 US Customers in Last 365 Days and Congratulates NFL "Team VINIA" Prospects on Draft Day Success
4.7/5 average rating based on over 2000 verified online customer reviews Over 25,000 new US customers and 50,000+ total orders... 
Via Newsfile
BioHarvest Sciences Named Honorable Mention in Wellness Category of Fast Company's 2023 World Changing Ideas Awards
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is... 
Via Newsfile
BioHarvest Sciences Contributing VINIA to NFL Training Camp Preparation
VINIA will be provided to over 140 NFL athletes preparing for the 2023 NFL SeasonFive House of Athlete Combine Trainees... 
Via Newsfile
BioHarvest Sciences to Host Virtual Shareholder Presentation May 4, 2pm ET
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or the... 
Via Newsfile
BioHarvest Sciences Hires Dr. Ilana Belzer as Chief Operating Officer
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 19, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest"... 
Via Newsfile
Topics Economy
Exposures Supply Chain
BioHarvest Sciences Announces Major Media Campaign to Focus on VINIA Real Stories
Multi tiered VINIA marketing campaign includes television and digital layersCampaign builds brand platform of Real People, Real Results, Real ScienceVancouver,... 
Via Newsfile
BioHarvest Sciences Collaborating with Yo Murphy and NFL Prospects to Build Awareness of Blood Flow Importance
NFL wide receiver-turned-trainer Yo Murphy educates players on the importance of using science-based solutions like VINIA® to optimize their... 
Via Newsfile
BioHarvest Sciences Announces Clinical Study in Patients with Multiple Sclerosis-Related Optic Neuritis
Study will assess the Capacity of its Red Grape Cell (RGC) Botanical Composition to Promote Eye HealthStudy is first to... 
Via Newsfile
BioHarvest Sciences Reports 2022 Sales Orders of USD 6.1M Representing 2.6X Increase over 2021
Finished 2022 with Q4 sales orders of USD 2.7M representing a 3.3X increase over Q4 2021Sales orders growth for 2023... 
Via Newsfile
BioHarvest Sciences Inc. Appoints Dr. George Garibaldi to Its Scientific Board of Advisors
Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors.His appointment demonstrates the... 
Via Newsfile
BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event January 19, 2023, at 2:00 PM E.T.
Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - January 11, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or "the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
Bioharvest Sciences Inc. 2022 CEO Letter to Shareholder Partners
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 29, 2022) - BioHarvest Sciences Inc.("BioHarvest" or the "Company") (CSE: BHSC)... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
BioHarvest Sciences Inc. Projects 2023 Revenue to Grow 3.0X-3.5X to a Range of USD $17M-$20M
Cash flow break-even projected for Q4 2023Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 15, 2022) - BioHarvest Sciences... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
Cannabis Industry Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences to Webcast Live at VirtualInvestorConferences.com October 27th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Cannabis Industry Virtual Investor Conference Agenda Announced for October 27th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) Featured in Virtual Coverage of the Life Sciences Investor Forum
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Business Intelligence Group Awards BioHarvest Sciences with the Prestigious Sustainability Leadership Award
The award recognizes the sustainability impact of BioHarvest's Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.